93 782 (Tamoxifen 20 mg)

Pill imprint 93 782 has been identified as Tamoxifen citrate 20 mg.

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer, prevention; breast cancer, metastatic; breast cancer; breast cancer, male (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 782

Tamoxifen citrate 20 mg 93 782
Tamoxifen citrate 20 mg 93 782
Tamoxifen citrate
Imprint:
93 782
Strength:
20 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-0782
Inactive Ingredients:
croscarmellose sodium
hypromellose 2910 (5 mPa.s)
lactose monohydrate
magnesium stearate
polyethylene glycol 400
povidone k30
corn starch
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-4287 Physicians Total Care Inc (repackager)
54569-5857 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)